Investing
Payments to Acquire Short-Term Investments
Pfizer Payments to Acquire Short-Term Investments decreased by 36.5% to $2.57B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.0%, from $2.82B to $2.57B. Over 4 years (FY 2021 to FY 2025), Payments to Acquire Short-Term Investments shows a downward trend with a -21.8% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
High levels of investment indicate strong cash reserves and a conservative treasury management strategy, while low levels may suggest cash is being deployed elsewhere.
Detailed definition
This represents the cash outflow used to purchase short-term financial instruments, such as treasury bills or money mark...
Peer comparison
Standard for companies with significant cash balances; peers will show similar activity based on their liquidity management policies.
Metric ID:
investing_payments_to_acquire_short_term_investmentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.93B | $10.30B | $12.18B | $8.76B | $10.18B | $10.76B | $6.68B | $6.67B | $14.34B | $9.13B | $836.00M | $797.00M | $457.00M | $2.70B | $6.18B | $2.82B | $3.26B | $4.22B | $4.05B | $2.57B |
| QoQ Change | — | +3.7% | +18.2% | -28.1% | +16.2% | +5.7% | -37.9% | -0.3% | +115.2% | -36.3% | -90.8% | -4.7% | -42.7% | +491.5% | +128.5% | -54.3% | +15.6% | +29.5% | -4.1% | -36.5% |
| YoY Change | — | — | — | — | +2.5% | +4.5% | -45.1% | -23.9% | +40.9% | -15.2% | -87.5% | -88.0% | -96.8% | -70.4% | +638.8% | +254.2% | +613.8% | +56.2% | -34.5% | -9.0% |
Range$457.00M – $14.34B
CAGR-24.8%
Avg YoY Growth+71.3%
Median YoY Growth-12.1%
Current Streak2 quarters decline
Payments to Acquire Short-Term Investments at Other Companies
Frequently Asked Questions
- What is Pfizer's payments to acquire short-term investments?
- Pfizer (PFE) reported payments to acquire short-term investments of $2.57B in Q1 2026.
- How has Pfizer's payments to acquire short-term investments changed year-over-year?
- Pfizer's payments to acquire short-term investments decreased by 9.0% year-over-year, from $2.82B to $2.57B.
- What is the long-term trend for Pfizer's payments to acquire short-term investments?
- Over 4 years (2021 to 2025), Pfizer's payments to acquire short-term investments has grown at a -21.8% compound annual growth rate (CAGR), from $38.46B to $14.36B.
- What does payments to acquire short-term investments mean?
- Cash spent on buying short-term, liquid financial investments.